 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
Arrowhead Pharmaceuticals
ARWR
conference date: February 6, 2024 @ 1:30 PM Pacific Time
Arrowhead Pharmaceuticals Remains a Buy For Pipeline Potential [May 19, 2023 at Seeking Alpha]
Accumulate Arrowhead For Its RNAi Pipeline [January 17, 2022 at Seeking Alpha]
Arrowhead Pharmaceuticals Is A Smart Long-Term Opportunity [September 11, 2020 at Seeking Alpha]
Arrowhead Pharmaceuticals RNA Therapy Pipeline Is Promising [July 19, 2019 at Seeking Alpha]
Arrowhead Pharmaceuticals (ARWR) is a clinical-stage biotechnology company specializing in RNAi therapies for genetic diseases.
Arrowhead Pharmaceutical web site
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALNY |
| AMAT |
| AMGN |
| APRE |
| BIIB |
| BMY |
| CDTX |
| CLDX |
| FATE |
| GILD |
| GLYC |
| ILMN |
| INO |
| IONS |
| MCHP |
| MRNA |
| PLX |
| REGN |
| RNA |
| SAGE |
| SANA |
| SGEN |
| SYRS |
| VBLT |
| VRTX |
| VSTM |
| WBA |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2023 William P. Meyers